<- Go Home
Drugs Made In America Acquisition Corp.
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
Market Cap
$357.4M
Volume
79.8K
Cash and Equivalents
$6.1K
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$10.60
52 Week Low
$9.95
Dividend
N/A
Price / Book Value
-49.20
Price / Earnings
56.45
Price / Tangible Book Value
-49.20
Enterprise Value
$357.4M
Enterprise Value / EBITDA
N/A
Operating Income
-$2.8M
Return on Equity
158.23%
Return on Assets
-1.46
Cash and Short Term Investments
$6.1K
Debt
N/A
Equity
-$7.3M
Revenue
N/A
Unlevered FCF
-$1.5M
Sector
Capital Markets
Category
N/A